cache/e109f9d1b57cf559ca0da1a27de0f41ae9fa1d501fa02568b354cb7c90fcc462

PL:KATOWICE:KOLEJOWY

Okręgowy Szpital Kolejowy w Katowicach

  • Privately Held

Company Overview

Metric
Company NameOkręgowy Szpital Kolejowy w KatowicachWienerberger AG
SymbolWIE
MSH IDPL:KATOWICE:KOLEJOWYCOM:WIENERBERGER
MarketPRIVATESTOCKS
SectorHealthcare & Health ServicesBasic Materials
IndustryMedical FacilitiesConstruction Materials
CountryPLAT
Stage
Employee Count20.37K
Websitekolejowy.katowice.plwienerberger.com
LinkedIn
Founders

Market Metrics

Metric
Market Cap3.52B
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Financial Performance

Metric
Revenue4.46B
Revenue (LTM)
Revenue (NTM)
Gross Profit1.70B
EBITDA829.76M
Operating Income526.84M
Net Income353.16M
EPS3.35
Diluted EPS3.35
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Growth Metrics

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Profitability Ratios

Metric
Gross Profit Margin0.38
Operating Profit Margin0.12
EBITDA Margin0.19
Net Profit Margin0.08
Return on Equity0.13
Return on Assets0.06
Return on Capital Employed0.12

Valuation Multiples

Metric
P/E Ratio8.17
P/B Ratio1.21
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio0.91
EV Multiple6.08

Operational Metrics

Metric
Days Sales Outstanding
Days Payables Outstanding43.80
Days Inventory Outstanding189.75
Operating Cycle254.06
Cash Conversion Cycle202.52
Asset Turnover0.77

Cash Flow Metrics

Metric
Operating Cash Flow435.32M
Free Cash Flow148.46M
Cash Flow to Debt0.27
Operating Cash Flow/Sales0.11
Free Cash Flow Yield0.02

Balance Sheet Metrics

Metric
Cash & Equivalents437.39M
Accounts Receivable73.83M
Inventory1.22B
Goodwill
Debt to Capitalization0.46
Debt to Assets
Current Ratio1.38
Quick Ratio0.75

Efficiency Metrics

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue0.03